Atea Pharmaceuticals, Inc.
AVIR
$3.10
$0.010.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 1,480.57% | -29.68% | |||
| Gross Profit | -1,480.57% | 29.68% | |||
| SG&A Expenses | -20.40% | -4.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.73% | 6.10% | |||
| Operating Income | -9.73% | -6.10% | |||
| Income Before Tax | -13.26% | -8.47% | |||
| Income Tax Expenses | -5.31% | 1.97% | |||
| Earnings from Continuing Operations | -13.15% | -8.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.15% | -8.43% | |||
| EBIT | -9.73% | -6.10% | |||
| EBITDA | -9.76% | -6.12% | |||
| EPS Basic | -19.88% | -10.26% | |||
| Normalized Basic EPS | -19.39% | -10.56% | |||
| EPS Diluted | -19.88% | -10.26% | |||
| Normalized Diluted EPS | -19.39% | -10.56% | |||
| Average Basic Shares Outstanding | -5.61% | -1.66% | |||
| Average Diluted Shares Outstanding | -5.61% | -1.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||